EV/EBITDA:
-6.77+0.27(+3.84%)Summary
- As of today (September 16, 2025), RARE EV/EBITDA is -6.77, with a rise of +0.27 (+3.84%) during the most recent trading session on September 15, 2025.
- Over the past year, RARE EV/EBITDA has increased by +4.03 (+37.31%).
- RARE EV/EBITDA is now -81.02% below its all-time high of -3.74.
Performance
RARE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RARE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.8% | -3.8% | -4.3% |
| 1 m1 month | +2.0% | -2.0% | -2.3% |
| 3 m3 months | +17.7% | -19.1% | -22.6% |
| 6 m6 months | +15.1% | -20.2% | -26.3% |
| ytdytd | +19.0% | -24.0% | -31.1% |
| 1 y1 year | +37.3% | -42.9% | -50.6% |
| 5 y5 years | +41.6% | -28.9% | -64.3% |
RARE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.77 | at high | -7.40 | +8.5% |
| 3 m | 3-month | -6.22 | -8.8% | -9.32 | +27.4% |
| 6 m | 6-month | -6.22 | -8.8% | -9.32 | +27.4% |
| 1 y | 1-year | -6.22 | -8.8% | -11.20 | +39.5% |
| 3 y | 3-year | -4.03 | -68.0% | -11.20 | +39.5% |
| 5 y | 5-year | -4.03 | -68.0% | -35.77 | +81.1% |
| alltime | all time | -3.74 | -81.0% | -79.27 | +91.5% |
RARE EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.77(-19.0%) |
| 2024 | -8.36(+5.7%) |
| 2023 | -7.91(+46.2%) |
| 2022 | -5.41(-63.6%) |
| 2021 | -14.88(-46.2%) |
| 2020 | -27.64(+456.1%) |
| Date | Value |
|---|---|
| 2019 | -4.97(-0.2%) |
| 2018 | -4.98(-12.9%) |
| 2017 | -5.72(-44.5%) |
| 2016 | -10.30(-61.6%) |
| 2015 | -26.82(+23.9%) |
| 2014 | -21.64 |
FAQ
- What is Ultragenyx Pharmaceutical Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical Inc.?
- What is RARE EV/EBITDA year-to-date change?
- What is Ultragenyx Pharmaceutical Inc. EV/EBITDA year-on-year change?
What is Ultragenyx Pharmaceutical Inc. EV/EBITDA?
The current EV/EBITDA of RARE is -6.77
What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high EV/EBITDA is -3.74
What is RARE EV/EBITDA year-to-date change?
Ultragenyx Pharmaceutical Inc. EV/EBITDA has changed by +1.59 (+19.02%) since the beginning of the year
What is Ultragenyx Pharmaceutical Inc. EV/EBITDA year-on-year change?
Over the past year, RARE EV/EBITDA has changed by +4.03 (+37.31%)